Show simple item record

FieldValueLanguage
dc.contributor.authorWurzel, Danielleen_AU
dc.contributor.authorMcMinn, Alissaen_AU
dc.contributor.authorHoq, Monsurulen_AU
dc.contributor.authorBlyth, Christopher Cen_AU
dc.contributor.authorBurgner, Daviden_AU
dc.contributor.authorTosif, Shidanen_AU
dc.contributor.authorButtery, Jimen_AU
dc.contributor.authorCarr, Jeremyen_AU
dc.contributor.authorClark, Julia Een_AU
dc.contributor.authorCheng, Allen Cen_AU
dc.contributor.authorDinsmore, Nicoleen_AU
dc.contributor.authorFrancis, Joshua Reginalden_AU
dc.contributor.authorKynaston, Anneen_AU
dc.contributor.authorLucas, Ryanen_AU
dc.contributor.authorMarshall, Helenen_AU
dc.contributor.authorMcMullan, Brendanen_AU
dc.contributor.authorSingh-Grewal, Davinderen_AU
dc.contributor.authorWood, Nicholasen_AU
dc.contributor.authorMacartney, Kristineen_AU
dc.contributor.authorBritton, Phil Nen_AU
dc.contributor.authorCrawford, Nigel Wen_AU
dc.date.accessioned2021-11-26T05:04:56Z
dc.date.available2021-11-26T05:04:56Z
dc.date.issued2021
dc.identifier.urihttps://hdl.handle.net/2123/26973
dc.description.abstractOBJECTIVE: To present Australia-wide data on paediatric COVID-19 and multisystem inflammatory syndromes to inform health service provision and vaccination prioritisation. DESIGN: Prospective, multicentre cohort study. SETTING: Eight tertiary paediatric hospitals across six Australian states and territories in an established research surveillance network-Paediatric Active Enhanced Disease (PAEDS). PARTICIPANTS: All children aged <19 years with SARS-CoV-2 infection including COVID-19, Paediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS) and Kawasaki-like disease TS infection (KD-TS) treated at a PAEDS site from 24 March 2020 to 31 December 2020. INTERVENTION: Laboratory-confirmed SARS-CoV-2 infection. MAIN OUTCOME: Incidence of severe disease among children with COVID-19, PIMS-TS and KD-TS. We also compared KD epidemiology before and during the COVID-19 pandemic. RESULTS: Among 386 children with SARS-CoV-2 infection, 381 (98.7%) had COVID-19 (median 6.3 years (IQR 2.1-12.8),53.3% male) and 5 (1.3%) had multisystem inflammatory syndromes (PIMS-TS, n=4; KD-TS, n=1) (median 7.9 years (IQR 7.8-9.8)). Most children with COVID-19 (n=278; 73%) were Australian-born from jurisdictions with highest community transmission. Comorbidities were present in 72 (18.9%); cardiac and respiratory comorbidities were most common (n=32/72;44%). 37 (9.7%) children with COVID-19 were hospitalised, and two (0.5%) required intensive care. Postinfective inflammatory syndromes (PIMS-TS/KD-TS) were uncommon (n=5; 1.3%), all were hospitalised and three (3/5; 60%) required intensive care management. All children recovered and there were no deaths. KD incidence remained stable during the pandemic compared with prepandemic. CONCLUSIONS: Most children with COVID-19 had mild disease. Severe disease was less frequent than reported in high prevalence settings. Preventative strategies, such as vaccination, including children and adolescents, could reduce both the acute and postinfective manifestations of the disease.en_AU
dc.language.isoenen_AU
dc.subjectCOVID-19en_AUI
dc.subjectCoronavirusen_AUI
dc.titleProspective characterisation of SARS-CoV-2 infections among children presenting to tertiary paediatric hospitals across Australia in 2020: a national cohort studyen_AU
dc.typeArticleen_AU
dc.identifier.doi10.1136/bmjopen-2021-054510
dc.relation.otherNew South Wales Department of Healthen_AU
dc.relation.otherNational Health and Medical Research Councilen_AU


Show simple item record

Associated file/s

There are no files associated with this item.

Associated collections

Show simple item record

There are no previous versions of the item available.